EVALUATION OF THE EFFECT AND SAFETY OF PONATINIB AS THIRD-LINE TREATMENT FOR PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE

Bildiriler > Özet Bildiri · 2016

Yazarlar: P. PATIR, Ayşegül UYSAL, M. DURAN, Nur SOYER, Filiz VURAL, Güray SAYDAM

7th International Eurasian Hematology Congress, Türkiye, İstanbul, Uluslararası, Sözlü Sunum, Özet Bildiri, 2016-2016, Wos, cilt 49

Detay görüntüle